News

Published on 23 Feb 2024 on Simply Wall St. via Yahoo Finance

Earnings Update: Bicycle Therapeutics plc (NASDAQ:BCYC) Just Reported Its Yearly Results And...


Article preview image

It's been a good week for Bicycle Therapeutics plc (NASDAQ:BCYC) shareholders, because the company has just released its latest full-year results, and the shares gained 8.6% to US$23.98. Revenues of US$27m came in 9.7% below estimates, but statutory losses were slightly better than expected, at US$5.08 per share. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. We thought readers would find it interesting to see the analysts latest (statutory) post-earnings forecasts for next year.

See our latest analysis for Bicycle Therapeutics

earnings-and-revenue-growthearnings-and-revenue-growth

NASDAQ.BCYC price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Earnings Update: Bicycle Therapeutics plc (NASDAQ:BCYC) Just Reported Its Yearly Results And...

It's been a good week for Bicycle Therapeutics plc (NASDAQ:BCYC) shareholders, because the compan...

Simply Wall St. via Yahoo Finance 23 Feb 2024

Bicycle Therapeutics PLC CEO Kevin Lee Sells 8,703 Shares

On January 3, 2024, CEO Kevin Lee sold 8,703 shares of Bicycle Therapeutics PLC (NASDAQ:BCYC), ac...

GuruFocus.com via Yahoo Finance 5 Jan 2024

Bicycle Therapeutics plc (NASDAQ:BCYC) Analysts Just Trimmed Their Revenue Forecasts By 13%

One thing we could say about the analysts on Bicycle Therapeutics plc (NASDAQ:BCYC) - they aren't...

Simply Wall St. via Yahoo Finance 7 Nov 2023

Bicycle Therapeutics PLC (BCYC) Reports Q3 2023 Financial Results and Upcoming R&D Day

<img src=https://s.yimg.com/ny/api/res/1.2/2idlItQ0lk.j39wOtSpuuQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyM...

GuruFocus.com via Yahoo Finance 2 Nov 2023

An excellent week for Bicycle Therapeutics plc's (NASDAQ:BCYC) institutional owners who own 64% as...

Key Insights Given the large stake in the stock by institutions, Bicycle Therapeutics' stock pric...

Simply Wall St. via Yahoo Finance 7 Oct 2023

Bicycle (BCYC) to Begin Pivotal Bladder Cancer Study, Stock Up

Bicycle Therapeutics BCYC, a clinical-stage company, announced moving forward with its decision t...

Zacks via Yahoo Finance 12 Sep 2023

Bicycle Therapeutics PLC Sponsored ADR (BCYC) Surges 9.0%: Is This an Indication of Further Gains?

Bicycle Therapeutics PLC Sponsored ADR (BCYC) shares soared 9% in the last trading session to clo...

Zacks via Yahoo Finance 12 Sep 2023

Investors in Bicycle Therapeutics (NASDAQ:BCYC) have seen favorable returns of 39% over the past...

One simple way to benefit from the stock market is to buy an index fund. But if you buy good busi...

Simply Wall St. via Yahoo Finance 18 Jul 2023

Bicycle Therapeutics PLC Sponsored ADR (BCYC) Soars 19.3%: Is Further Upside Left in the Stock?

Bicycle Therapeutics PLC Sponsored ADR (BCYC) shares rallied 19.3% in the last trading session to...

Zacks via Yahoo Finance 14 Jul 2023

Wall Street Analysts Think Bicycle Therapeutics PLC Sponsored ADR (BCYC) Could Surge 146.31%: Read...

Shares of Bicycle Therapeutics PLC Sponsored ADR (BCYC) have gained 2.8% over the past four weeks...

Zacks via Yahoo Finance 4 May 2023